Kate Haviland, Chief Operating Officer at Blueprint Medicines Corp (BPMC), sold 6,286 shares at $85.49 ($537K) on 2020-09-22, disclosed to the SEC on 2020-09-24.
Open-market sale of $537k BPMC by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $85.49 | 3,143 | $269K | 50.0% |
| 2 | $85.49 | 3,143 | $269K | 50.0% |
| Total | $85.49 avg | 6,286 | $537K | 100% |
| Filing → |
| BPMC | SELL | 2025-01-23 | $319K | — | Filing → |
| BPMC | SELL | 2024-12-03 | $396K | — | Filing → |
| BPMC | SELL | 2024-03-11 | $2.3M | — | Filing → |